Inventor · disambiguated record
Eli A. Stahl
Also filed as: STAHL ELI A
2 granted patents·4 pending applications·0 citations·filing 2021–2025
28Inventor score
Files withREGENERON PHARMA6
Top patents by PatentIndex Score
6 records- 0168US2025115918A1Treatment Of Uveitis With Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0265US12370257B2Materials and methods of treating MHC-I-opathy risk haplotypesREGENERON PHARMA·Filed 2022·Granted Jul 29, 2025·0 cites·13 claims
- 0362US12157891B2Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitorsREGENERON PHARMA·Filed 2022·Granted Dec 3, 2024·0 cites·9 claims
- 0462US2025375519A1Materials And Methods Of Treating MHC-1-Opathy Risk HaplotypesREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0559US2024238384A1Treatment Of B27-Negative Uveitis With Inositol Polyphosphate Multikinase (IPMK) Therapeutic Agents Or Indoleamine 2,3-dioxygenase 2 (IDO2) AgonistsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0647US2023059929A1Modulation Of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2)-Mediated Immune ResponseREGENERON PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eli A. Stahl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →